These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25702849)

  • 1. Novel fused tetrathiocines as antivirals that target the nucleocapsid zinc finger containing protein of the feline immunodeficiency virus (FIV) as a model of HIV infection.
    Asquith CR; Meli ML; Konstantinova LS; Laitinen T; Poso A; Rakitin OA; Hofmann-Lehmann R; Allenspach K; Hilton ST
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1352-5. PubMed ID: 25702849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Substituted 1,2,3-Dithiazoles as Inhibitors of the Feline Immunodeficiency Virus (FIV) Nucleocapsid Protein via a Proposed Zinc Ejection Mechanism.
    Asquith CR; Konstantinova LS; Laitinen T; Meli ML; Poso A; Rakitin OA; Hofmann-Lehmann R; Hilton ST
    ChemMedChem; 2016 Oct; 11(19):2119-2126. PubMed ID: 27511289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Pentathiepin Functionality as an Inhibitor of Feline Immunodeficiency Virus (FIV) via a Potential Zinc Ejection Mechanism, as a Model for HIV Infection.
    Asquith CRM; Laitinen T; Konstantinova LS; Tizzard G; Poso A; Rakitin OA; Hofmann-Lehmann R; Hilton ST
    ChemMedChem; 2019 Feb; 14(4):454-461. PubMed ID: 30609219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infection.
    Asquith CR; Meli ML; Konstantinova LS; Laitinen T; Peräkylä M; Poso A; Rakitin OA; Allenspach K; Hofmann-Lehmann R; Hilton ST
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2640-4. PubMed ID: 24813732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection.
    Asquith CRM; Sil BC; Laitinen T; Tizzard GJ; Coles SJ; Poso A; Hofmann-Lehmann R; Hilton ST
    Bioorg Med Chem; 2019 Sep; 27(18):4174-4184. PubMed ID: 31395510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection.
    Laitinen T; Meili T; Koyioni M; Koutentis PA; Poso A; Hofmann-Lehmann R; Asquith CRM
    Bioorg Med Chem; 2022 Aug; 68():116834. PubMed ID: 35653871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection.
    Asquith CRM; Meili T; Laitinen T; Baranovsky IV; Konstantinova LS; Poso A; Rakitin OA; Hofmann-Lehmann R
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1765-1768. PubMed ID: 31101470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single aromatic residue location alters nucleic acid binding and chaperone function of FIV nucleocapsid protein.
    Wu H; Wang W; Naiyer N; Fichtenbaum E; Qualley DF; McCauley MJ; Gorelick RJ; Rouzina I; Musier-Forsyth K; Williams MC
    Virus Res; 2014 Nov; 193():39-51. PubMed ID: 24915282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional domains in the feline immunodeficiency virus nucleocapsid protein.
    Manrique ML; Rauddi ML; González SA; Affranchino JL
    Virology; 2004 Sep; 327(1):83-92. PubMed ID: 15327900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
    J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model.
    Schito ML; Goel A; Song Y; Inman JK; Fattah RJ; Rice WG; Turpin JA; Sher A; Appella E
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):91-101. PubMed ID: 12639244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of the feline-immunodeficiency-virus envelope glycoprotein 36 ectodomain for the development of new antivirals.
    Desmaris F; Lemaire D; Ricard-Blum S; Chatrenet B; Forest E
    Biochem J; 2005 Jul; 389(Pt 2):559-67. PubMed ID: 15799719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the activity of antivirals towards feline immunodeficiency virus in different cell culture systems.
    van der Meer FJ; Schuurman NM; Balzarini J; Egberink HF
    Antiviral Res; 2007 Nov; 76(2):198-201. PubMed ID: 17640744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA.
    Moscardini M; Pistello M; Bendinelli M; Ficheux D; Miller JT; Gabus C; Le Grice SF; Surewicz WK; Darlix JL
    J Mol Biol; 2002 Apr; 318(1):149-59. PubMed ID: 12054775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus.
    de Parseval A; Chatterji U; Morris G; Sun P; Olson AJ; Elder JH
    Nat Struct Mol Biol; 2005 Jan; 12(1):60-6. PubMed ID: 15592478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus.
    D'Ursi AM; Giannecchini S; Esposito C; Alcaro MC; Sichi O; Armenante MR; Carotenuto A; Papini AM; Bendinelli M; Rovero P
    Chembiochem; 2006 May; 7(5):774-9. PubMed ID: 16566046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline CD8+ cells induced with FIV infected, irradiated T cells produce multiple anti-FIV factors.
    Li Z; Phadke A; Weaver EA; Ball JM; Collisson EW
    Dev Comp Immunol; 2005; 29(9):809-24. PubMed ID: 15936436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feline immunodeficiency virus infection--causative agent of an acquired immunodeficiency syndrome in cats.
    Hartmann K
    Eur J Med Res; 1996 Nov; 1(12):547-50. PubMed ID: 9438159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
    Arthur LO; Bess JW; Chertova EN; Rossio JL; Esser MT; Benveniste RE; Henderson LE; Lifson JD
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S311-9. PubMed ID: 9814959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.